BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 667800)

  • 1. Carcinoembryonic antigen (CEA) in plasma of patients with carcinoma of the bladder/urethra.
    Orjasaeter H; Fosså SD; Schjølseth SA; Fjaestad K
    Cancer; 1978 Jul; 42(1):287-95. PubMed ID: 667800
    [No Abstract]   [Full Text] [Related]  

  • 2. Carcinoembryonic antigen in patients with urologic cancers.
    Guinan P; Ablin RJ; Barakat H; John T; Sadoughi N; Bush IM
    Urol Res; 1973 Oct; 1(3):101-5. PubMed ID: 4804082
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma levels of CEA as a prognostic marker in carcinoma of urinary bladder.
    Alsabti EA; Saffo MH
    Urol Int; 1979; 34(5):387-92. PubMed ID: 494440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoembryonic antigen and bladder carcinoma.
    Ionescu G; Romas NA; Ionascu L; Bennett S; Tannenbaum M; Veeneman RJ; Lattimer JK
    J Urol; 1976 Jan; 115(1):46-8. PubMed ID: 1107601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of carcinoembryonic antigen in tissue, serum and urine in patients with transitional cell carcinoma of the urinary bladder.
    Jakse G; Rauschmeier H; Rosmanith P; Hofstädter F
    Urol Int; 1983; 38(3):121-5. PubMed ID: 6868210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biologic significance and clinical value of carcinoembryonic antigen in tissues in transitional cell carcinoma of the urinary tract].
    Yang SC
    Zhonghua Wai Ke Za Zhi; 1989 Apr; 27(4):228-30, 254. PubMed ID: 2805992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of CEA assay in tissue, serum and urine in patients with transitional cell carcinoma of the bladder.
    Alampi G; Ronchi E; Galassi A; Soli M; Botteghi B; Bercovich E
    Arch Anat Cytol Pathol; 1985; 33(4):193-6. PubMed ID: 3904640
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
    Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
    Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carcinoembryonic antigen (CEA) in carcinoma of the upper urinary tract and bladder. Immunohistochemical study].
    Lanzafame S; Puzzo L; Di Naso C; Di Marco G; Ranno S; Minardi G
    Pathologica; 1986; 78(1056):451-8. PubMed ID: 3302887
    [No Abstract]   [Full Text] [Related]  

  • 10. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
    Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
    [No Abstract]   [Full Text] [Related]  

  • 11. Proceedings: Tumors of the urethra in men and women.
    Grabstald H
    Cancer; 1973 Nov; 32(5):1236-55. PubMed ID: 4757914
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas.
    Jautzke G; Altenaehr E
    Cancer; 1982 Nov; 50(10):2052-6. PubMed ID: 6751517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic-like antigen in the urine of patients with carcinoma of the bladder and normal controls.
    Guinan P; Ablin RJ; Sadoughi N; Bush IM
    J Surg Oncol; 1974; 6(2):127-31. PubMed ID: 4822898
    [No Abstract]   [Full Text] [Related]  

  • 14. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
    Nakatsu H; Kobayashi I; Onishi Y; Igawa M; Ito H; Tahara E; Nihira H
    J Urol; 1984 Feb; 131(2):252-7. PubMed ID: 6366250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunologic indices of patients with transitional cell carcinoma of the urinary bladder].
    Bkhatta AD; Makhlin NV
    Urol Nefrol (Mosk); 1984; (2):67-70. PubMed ID: 6372193
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunoperoxidase detection of carcinoembryonic antigen and blood group substances in papillary transitional cell carcinoma of the bladder.
    Wiley EL; Mendelsohn G; Droller MJ; Eggleston JC
    J Urol; 1982 Aug; 128(2):276-80. PubMed ID: 7050419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].
    Takashi M; Murase T; Mitsuya H; Koshikawa T; Nagura H; Haimoto H
    Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma and urinary CEA-assay in patients with urological tumours (author's transl)].
    Hering H; Hering FJ; Weidner W
    Urologe A; 1976 Nov; 15(6):300-3. PubMed ID: 1006894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of adenocarcinomas of the colorectum with low levels of preoperative plasma carcinoembryonic antigen (CEA).
    Jubert AV; Talbott TM; Maycroft TM
    Cancer; 1978 Aug; 42(2):635-9. PubMed ID: 679156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors].
    Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T
    Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.